Cantor Fitzgerald Initiates Keros Therapeutics(KROS.US) With Buy Rating
Scotiabank Initiates Coverage On Keros Therapeutics With Sector Outperform Rating, Announces Price Target of $77
Express News | Keros Therapeutics Appoints Yung H. Chyung, M.d., as Chief Medical Officer
"Weight-loss miracle drug" causing muscle loss, biotechnology companies like Regeneron Pharmaceuticals (REGN.US) are developing new treatments.
Wegovy and Zepbound, along with other GLP-1 class drugs, have significant effects on weight loss, but this weight loss largely reduces muscle mass.
Weight Loss Drugs Have One Big Issue; These Companies Want to Fix It
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ironwood Pharma (IRWD), Travere Therapeutics (TVTX) and Keros Therapeutics (KROS)